CompletedNCT03345342
A Study of Paliperidone Palmitate 6-Month Formulation
Medication studyAges 18–70Multiple countriesSchizophrenia
Understand this study
Who was this study for?
Listed age limits: 18 years to 70 years.
- Listed locations
- Rogers, United States · Anaheim, United States and 118 more locationsSee all locations and recruitment
- Activities
- Medication described in the protocol · Placebo described in the protocol; its role is not resolved here
- Compensation
- Payment and expense reimbursement have not been verified.
Study information
Study start dateStarted: November 20, 2017
- Recruitment status
- Completed
- Enrollment listed in the registry
- 841
- Sponsor
- Janssen Research & Development, LLC
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Medication / drug, OTHER
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States, Australia, France, ...
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT03345342
- Official title
Show the full official title
A Double-blind, Randomized, Active-controlled, Parallel-group Study of Paliperidone Palmitate 6-Month Formulation
Recruitment & locations
CompletedRogers, United States · Anaheim, United States · Costa Mesa, United States
117 more locations
- Garden Grove, United States
- Lemon Grove, United States
- Oakland, United States
- San Rafael, United States
- Hialeah, United States
- Miami, United States
- Tampa, United States
- Atlanta, United States
- Chicago, United States
- Hoffman Estates, United States
- Wichita, United States
- Boston, United States
- Grand Rapids, United States
- St Louis, United States
- Glen Oaks, United States
- Hickory, United States
- Columbus, United States
- Dayton, United States
- Philadelphia, United States
- Dallas, United States
- Salt Lake City, United States
- Buenos Aires, Argentina
- Córdoba, Argentina
- La Plata, Argentina
- Rosario, Argentina
- Elizabeth Vale, Australia
- Noble Park, Australia
- Curitiba, Brazil
- Itapira, Brazil
- Porto Alegre, Brazil
- Rio de Janeiro, Brazil
- São Paulo, Brazil
- Burgas, Bulgaria
- Pazardzhik, Bulgaria
- Plovdiv, Bulgaria
- Radnevo, Bulgaria
- Sofia, Bulgaria
- Brno, Czechia
- Hradec Kralove-Vekose, Czechia
- Pilsen, Czechia
- Prague, Czechia
- Bordeaux, France
- Montpellier, France
- Nîmes, France
- Paris, France
- Toulon, France
- Hong Kong, Hong Kong
- Budapest, Hungary
- Győr, Hungary
- Kalocsa, Hungary
- Miskolc, Hungary
- Ahmedabad, India
- Chennai, India
- Hyderabad, India
- Madurai, India
- Mangalore, India
- Manipal, India
- Pune, India
- Varanasi, India
- Cagliari, Italy
- Lecce, Italy
- Naples, Italy
- Roma, Italy
- Ipoh, Malaysia
- Kuala Lumpur, Malaysia
- Kuching, Malaysia
- Mexico City, Mexico
- Monterrey, Mexico
- San Luis Potosí City, Mexico
- Bialystok, Poland
- Chełmno, Poland
- Gdansk, Poland
- Gorlice, Poland
- Leszno, Poland
- Lublin, Poland
- Pruszcz Gdański, Poland
- Pruszków, Poland
- Torun, Poland
- Moscow, Russia
- Nizny Novgorod, Russia
- Saint Petersburg, Russia
- Saratov, Russia
- St.Peterburg, Russia
- Tomsk, Russia
- Yekaterinburg, Russia
- Cape Town, South Africa
- Pretoria, South Africa
- Welgemoed, South Africa
- Gwangju, South Korea
- Gyeonggi-do, South Korea
- Jeonju, South Korea
- Seoul, South Korea
- Barcelona, Spain
- Bilbao, Spain
- Oviedo, Spain
- Ponferrada, Spain
- Valencia, Spain
- Zamora, Spain
- Tainan, Taiwan
- Taipei, Taiwan
- Taoyuan, Taiwan
- Ankara, Türkiye
- Istanbul, Türkiye
- Konya, Türkiye
- Sakarya, Türkiye
- Hlevakha, Ukraine
- Kharkiv, Ukraine
- Kherson, Ukraine
- Kyiv, Ukraine
- Lviv, Ukraine
- Oleksandrivka, Ukraine
- Smila, Ukraine
- Vinnytsia, Ukraine
- Czechia
- China
- Russia
- Türkiye
Questions about this study
Who is behind this study?
The study sponsor is Janssen Research & Development, LLC.
Did this study involve medication?
Yes. The study involved medication, including PP6M, PP3M 350 mg eq., PP3M 525 mg eq. and PP1M.
Who was this study for?
Listed age limits: 18 years to 70 years.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meRelated studies
Paliperidone Palmitate Compared With Oral Antipsychotic Treatment for schizophrenia
18F-Dihydroxyphenylalanine (DOPA) Positron Emission Tomography (PET) Study to Explore Dopamine Synthesis Capacity in the Whole Striatum After 2 Weeks of Treatment With Ralmitaront or Placebo in Participants With Schizophrenia